Its increase in human muscle samples, the strong correlation with TGF-β mRNA levels, and the progressive increase in the ALS mouse starting at a time point similar to the other Smads (60 d) indicate that this family member could also be a biomarker of disease progression. Here, TGFB1 is linked to amyotrophic lateral sclerosis.